Jpmorgan Chase & Co »

Bridgebio Pharma Inc put shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Bridgebio Pharma Inc put shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Bridgebio Pharma Inc put

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma Inc put held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma Inc put by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 23k 51.94
2025-03-31 $1.4M 40k 34.57
2024-12-31 $74k 2.7k 27.44
2024-09-30 $69k 2.7k 25.46
2023-06-30 $408k 24k 17.20
2023-03-31 $133k 8.0k 16.63
2021-12-31 $1.3M 77k 16.68

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Bridgebio Pharma Inc put

Group One Trading
Simplex Trading
Jpmorgan Chase & Co
IMC-Chicago

View all funds holding Bridgebio Pharma Inc put